Showing results (21-30 of 146) with videos related to
Sort By:
Pageof 15
Journal of Experimental Therapeutics & Oncology|June 26, 2003
Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient miceDaniel E Lopes de Menezes, Yanping Hu, Lawrence D MayerDie Pharmazie|August 17, 2000
Polymeric colloidal systems containing ethionamide: preparation and physico-chemical characterizationE Lopes, A R Pohlmann, V Bassani, et al.Journal De La Societe De Biologie|April 28, 2001
[Role of nitric oxide in heart failure]P Le Corvoisier, M E Lopes, J Su, et al.Ecology and Evolution|February 23, 2023
The future of suitable habitats of an endangered Neotropical grassland bird: A path to extinction?Ricardo C Meireles, Leonardo E Lopes, Gustavo R Brito, et al.American Journal of Health Promotion : AJHP|February 7, 1995
The impact of a videotape on smoking cessation among African-American womenC E Lopes, S Sussman, E R Galaif, et al.Cancer Research|August 12, 1998
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphomaD E Lopes de Menezes, L M Pilarski, T M AllenThrombosis and Haemostasis|January 1, 2019
Agonist-Evoked Increases in Intra-Platelet Zinc Couple to Functional ResponsesNiaz S Ahmed, Maria E Lopes Pires, Kirk A Taylor, et al.Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Insights into transcriptional regulation by FOXP3Bryan D Carson, Jared E Lopes, David M Soper, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicinD E Lopes de Menezes, N Hudon, N McIntosh, et al.International Journal of Biological Macromolecules|August 2, 2000
Molecular weight and antitumour activity of Zymomonas mobilis levansCalazans GMT, R C Lima, F P de França, et al.Pageof 15